GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Medicine  (3)
  • Psychology  (3)
Material
Publisher
Language
Years
FID
Subjects(RVK)
  • Medicine  (3)
  • Psychology  (3)
RVK
  • 1
    In: Psychotherapy and Psychosomatics, S. Karger AG, Vol. 90, No. 2 ( 2021), p. 127-136
    Abstract: Background: As the fight against the COVID-19 epidemic continues, medical workers may have allostatic load. Objective: During the reopening of society, medical and nonmedical workers were compared in terms of allostatic load. Methods: An online study was performed; 3,590 Chinese subjects were analyzed. Socio-demographic variables, allostatic load, stress, abnormal illness behavior, global well-being, mental status, and social support were assessed. Results: There was no difference in allostatic load in medical workers compared to nonmedical workers (15.8 vs. 17.8%; p = 0.22). Multivariate conditional logistic regression revealed that anxiety (OR = 1.24; 95% CI 1.18–1.31; p 〈 0.01), depression (OR = 1.23; 95% CI 1.17–1.29; p 〈 0.01), somatization (OR = 1.20; 95% CI 1.14–1.25; p 〈 0.01), hostility (OR = 1.24; 95% CI 1.18–1.30; p 〈 0.01), and abnormal illness behavior (OR = 1.49; 95% CI 1.34–1.66; p 〈 0.01) were positively associated with allostatic load, while objective support (OR = 0.84; 95% CI 0.78–0.89; p 〈 0.01), subjective support (OR = 0.84; 95% CI 0.80–0.88; p 〈 0.01), utilization of support (OR = 0.80; 95% CI 0.72–0.88; p 〈 0.01), social support (OR = 0.90; 95% CI 0.87–0.93; p 〈 0.01), and global well-being (OR = 0.30; 95% CI 0.22–0.41; p 〈 0.01) were negatively associated. Conclusions: In the post-COVID-19 epidemic time, medical and nonmedical workers had similar allostatic load. Psychological distress and abnormal illness behavior were risk factors for it, while social support could relieve it.
    Type of Medium: Online Resource
    ISSN: 0033-3190 , 1423-0348
    RVK:
    RVK:
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2021
    detail.hit.zdb_id: 1472321-9
    SSG: 5,2
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Psychotherapy and Psychosomatics, S. Karger AG, Vol. 89, No. 4 ( 2020), p. 242-250
    Abstract: 〈 b 〉 〈 i 〉 Objective: 〈 /i 〉 〈 /b 〉 We explored whether medical health workers had more psychosocial problems than nonmedical health workers during the COVID-19 outbreak. 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 An online survey was run from February 19 to March 6, 2020; a total of 2,182 Chinese subjects participated. Mental health variables were assessed via the Insomnia Severity Index (ISI), the Symptom Check List-revised (SCL-90-R), and the Patient Health Questionnaire-4 (PHQ-4), which included a 2-item anxiety scale and a 2-item depression scale (PHQ-2). 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 Compared with nonmedical health workers ( 〈 i 〉 n 〈 /i 〉 = 1,255), medical health workers ( 〈 i 〉 n 〈 /i 〉 = 927) had a higher prevalence of insomnia (38.4 vs. 30.5%, 〈 i 〉 p 〈 /i 〉 & #x3c; 0.01), anxiety (13.0 vs. 8.5%, 〈 i 〉 p 〈 /i 〉 & #x3c; 0.01), depression (12.2 vs. 9.5%; 〈 i 〉 p 〈 /i 〉 & #x3c; 0.04), somatization (1.6 vs. 0.4%; 〈 i 〉 p 〈 /i 〉 & #x3c; 0.01), and obsessive-compulsive symptoms (5.3 vs. 2.2%; 〈 i 〉 p 〈 /i 〉 & #x3c; 0.01). They also had higher total scores of ISI, GAD-2, PHQ-2, and SCL-90-R obsessive-compulsive symptoms ( 〈 i 〉 p 〈 /i 〉 ≤ 0.01). Among medical health workers, having organic disease was an independent factor for insomnia, anxiety, depression, somatization, and obsessive-compulsive symptoms ( 〈 i 〉 p 〈 /i 〉 & #x3c; 0.05 or 0.01). Living in rural areas, being female, and being at risk of contact with COVID-19 patients were the most common risk factors for insomnia, anxiety, obsessive-compulsive symptoms, and depression ( 〈 i 〉 p 〈 /i 〉 & #x3c; 0.01 or 0.05). Among nonmedical health workers, having organic disease was a risk factor for insomnia, depression, and obsessive-compulsive symptoms ( 〈 i 〉 p 〈 /i 〉 & #x3c; 0.01 or 0.05). 〈 b 〉 〈 i 〉 Conclusions: 〈 /i 〉 〈 /b 〉 During the COVID-19 outbreak, medical health workers had psychosocial problems and risk factors for developing them. They were in need of attention and recovery programs.
    Type of Medium: Online Resource
    ISSN: 0033-3190 , 1423-0348
    RVK:
    RVK:
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2020
    detail.hit.zdb_id: 1472321-9
    SSG: 5,2
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Psychotherapy and Psychosomatics, S. Karger AG, Vol. 91, No. 4 ( 2022), p. 253-264
    Abstract: 〈 b 〉 〈 i 〉 Introduction: 〈 /i 〉 〈 /b 〉 Anxiety disorders are prevalent mental conditions characterized by exaggerated anxious arousal and threat reactivity. Animal and human studies suggest an anxiolytic potential of the neuropeptide oxytocin (OT), yet, while a clinical application will require chronic administration protocols, previous human studies have exclusively focused on single-dose (acute) intranasal OT effects. 〈 b 〉 〈 i 〉 Objective: 〈 /i 〉 〈 /b 〉 To facilitate the translation of the potential anxiolytic mechanism of OT into clinical application, we determined whether the anxiolytic effects of OT are maintained with repeated (chronic) administration or are influenced by dose frequency and trait anxiety. 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 In a pre-registered double-blind randomized placebo-controlled pharmaco-fMRI trial the acute (single dose) as well as chronic effects of two different dose frequencies of OT (OT administered daily for 5 days or every other day) on emotional reactivity were assessed in 〈 i 〉 n 〈 /i 〉 = 147 individuals with high versus low trait anxiety (ClinicalTrials.gov ID: NCT03085654). 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 OT produced valence, dose frequency, and trait anxiety-specific effects, such that the low-frequency (intermittent) chronic dosage specifically attenuated a neural reactivity increase in amygdala-insula-prefrontal circuits observed in the high anxious placebo-treated subjects in response to threatening but not positive stimuli. 〈 b 〉 〈 i 〉 Conclusions: 〈 /i 〉 〈 /b 〉 The present trial provides the first evidence that low-dose frequency chronic intranasal OT has the potential to alleviate exaggerated neural threat reactivity in subjects with elevated anxiety levels, suggesting a treatment potential for anxiety disorders.
    Type of Medium: Online Resource
    ISSN: 0033-3190 , 1423-0348
    RVK:
    RVK:
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2022
    detail.hit.zdb_id: 1472321-9
    SSG: 5,2
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...